Almonty Industries Inc. (TSX:AII)
15.51
0.00 (0.00%)
Inactive · Last trade price on Jul 31, 2026
Almonty Industries Revenue
Almonty Industries had revenue of 42.99M CAD in the quarter ending June 30, 2026, with 497.73% growth. This brings the company's total for the last twelve months to 85.80M, up 204.55% year-over-year. In the year 2025, Almonty Industries had annual revenue of 32.51M with 12.75% growth.
Revenue (ttm)
85.80M
Revenue Growth
+204.55%
P/S Ratio
89.46
Revenue / Employee
146.65K
Employees
341
Market Cap
4.47B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Almonty Industries breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.51M | 3.68M | 12.75% |
| Dec 31, 2024 | 28.84M | 6.33M | 28.10% |
| Dec 31, 2023 | 22.51M | -2.29M | -9.22% |
| Dec 31, 2022 | 24.80M | 3.95M | 18.94% |
| Dec 31, 2021 | 20.85M | -4.25M | -16.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Almonty Industries News
- 3 hours ago - Almonty Industries Transcript: Investor Day 2026 - Transcripts
- 6 days ago - Almonty to Host Investor Day via Live Webcast on Monday, October 19, 2026 - Business Wire
- 6 days ago - Almonty Industries Inc (ALM) Shares Fall 6.7% -- GF Value Says Still Overvalued - GuruFocus
- 12 days ago - Almonty Industries Transcript: 20th International Investment Forum (IIF) - Transcripts
- 12 days ago - Almonty Industries Inc (ALM) Shares Fall 3.5% -- GF Value Says Still Overvalued - GuruFocus
- 16 days ago - Almonty Secures Corrective Disclosure from Pure Tungsten Following Successful Settlement Confirming Tiger Kim Held No Leadership Role at Almonty at Any Time - Business Wire
- 18 days ago - EADV 2026: Long-Term Disease Control for up to Five Years in Patients With Moderate-to-Severe Atopic Dermatitis Treated With Lebrikizumab - Business Wire
- 20 days ago - Almonty Issues Shareholder Letter and Provides Corporate Update - Business Wire